Post by Vetter Pharma

Great news from our Development Services team in Rankweil, Austria! 🙌🏼
Our site has successfully been recertified by the Austrian Agency for Health and Food Safety (AGES). After beginning operations in 2021 under AGES’ standard temporary manufacturing authorization, our Rankweil facility achieved permanent manufacturing authorization in 2023. This latest recertification followed a comprehensive 3-day inspection in which AGES experts rigorously evaluated our production and quality control processes, as well as our quality assurance systems and documentation. This renewed authorization allows us to continue delivering high quality clinical trial materials to customers around the world who are developing life‑changing therapies for patients in need. #CDMO #ClinicalManufacturing #DrugDevelopment